Viola, Brianna Belle .
HRN: 20-43-92 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2022
CEFTRIAXONE 1G (VIAL)
05/21/2022
05/27/2022
IV
430
Q12hours
Benign Febrile Seizure
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous SystemUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes